Piperazinyl-oxadiazoles as selective sphingosine-1-phosphate receptor agonists.
Bioorg Med Chem Lett
; 24(20): 4807-11, 2014 Oct 15.
Article
em En
| MEDLINE
| ID: mdl-25241927
ABSTRACT
The discovery of a new series of selective S1P1 agonists is described. This series of piperazinyl-oxadiazole derivatives was rapidly optimized starting from high-throughput screening hit 1 to afford potent and selective lead compound 10d. Further SAR studies showed that 10d was converted to the active phosphate metabolite 29 in vivo. Oral administration of compound 10d to rats was shown to induce lymphopenia at 3 mg/kg.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Oxidiazóis
/
Piperazinas
/
Receptores de Lisoesfingolipídeo
Limite:
Animals
Idioma:
En
Revista:
Bioorg Med Chem Lett
Assunto da revista:
BIOQUIMICA
/
QUIMICA
Ano de publicação:
2014
Tipo de documento:
Article